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Abstract 
Gingerols and shogaols are the primary non-volatile actives within ginger (Zingiber officinale). 
These compounds have demonstrated in vitro to exert 5-HT3 receptor antagonism which could 
benefit chemotherapy-induced nausea and vomiting (CINV). The site and mechanism of action by 
which these compounds interact with the 5-HT3 receptor is not fully understood although research 
indicates they may bind to a currently unidentified allosteric binding site. Using in silico 
techniques, such as molecular docking and GRID analysis, we have characterized the recently 
available murine 5-HT3 receptor by identifying sites of strong interaction with particular functional 
groups at both the orthogonal (serotonin) site and a proposed allosteric binding site situated at the 
interface between the transmembrane region and the extracellular domain. These were assessed 
concurrently with the top-scoring poses of the docked ligands and included key active gingerols, 
shogaols and dehydroshogaols as well as competitive antagonists (e.g. setron class of 
pharmacologically active drugs), serotonin and its structural analogues, curcumin and capsaicin, 
non-competitive antagonists and decoys.  Unexpectedly, we found that the ginger compounds and 
their structural analogs generally outscored other ligands at both sites. Our results correlated well 
with previous site-directed mutagenesis studies in identifying key binding site residues. We have 
identified new residues important for binding the ginger compounds. Overall, the results suggest 
that the ginger compounds and their structural analogues possess a high binding affinity to both 
sites. Notwithstanding the limitations of such theoretical analyses, these results suggest that the 
ginger compounds could act both competitively or non-competitively as has been shown for 
palonosetron and other modulators of CYS loop receptors.  
Keywords 
Ginger antiemetic Zingiber officinale gingerol shogaols chemotherapy induced nausea vomiting 
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Introduction 
Chemotherapy-induced nausea and vomiting (CINV) poses a major obstacle to patients often 
resulting in treatment cessation due to its severity and intolerability. Without appropriate 
antiemetic prophylaxis, up to ninety percent of all cancer patients receiving chemotherapy may 
experience nausea and/or vomiting.[1] In a recent review of the incidence of CINV, around twenty 
to forty percent of patients failed to respond to the current antiemetic treatments in relation to either 
vomiting or nausea with nausea being less well managed.[2] Nausea and delayed CINV are 
reported as particular challenges in clinical practice. Thus a significant impetus exists to develop 
more effective treatments. 
This study focuses on one of the primary pathways of emesis relating to CINV - the stimulation 
of vagal afferent nerves due to high levels of serotonin released from the mucosal enterochromaffin 
cells of the gut.[1, 3, 4] Serotonin allosterically activates the 5-HT Type 3 (or 5-HT3) ion channel 
by binding to a site distinct from the transmembrane region where channel opening occurs, 
facilitating neuronal depolarisation.[5] 
The cationic 5-HT3 receptor belongs to the CYS loop superfamily of ligand-gated ion channels 
(LGICs) along with nicotinic acetylcholine receptors (nAchR) and anionic g-aminobutyric acid 
receptor (GABAA and GABAC) and glycine receptor.[6] The function of 5-HT3 receptors is 
intricately fine-tuned by the binding of other molecules and ions in and adjacent to the channel, 
either extracellularly or within the membrane region. For example, all CYS-loop receptors are 
allosterically regulated by zinc ions binding at multiple locations.[7] Both anions and cations can 
enter the pore where ion filtering is controlled by specific residues lining the narrow region of the 
pore at the cytoplasmic end of the transmembrane domain (TMD) extending into the TMI-II 
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cytoplasmic loop.[8] A second ion filter controlling ion flow has been observed in the 5-HT3 
receptor at the intracellular transmembrane TMIII-IV loop.[9]  
 CYS loop receptors share significant structural similarity consisting of a pentameric assembly 
of subunits with three domains: N-terminal extracellular domain (ECD) with the 15 amino acid 
CYS-loop disulphide; transmembrane domain with four helices, MI-IV and intracellular domain 
(ICD) consisting of a long loop between MIII and MIV (Figure 1). The C-terminus is extracellular.  
Five distinct subunits (A to E) have been identified for the 5-HT3 receptor whereby A, B, C & E 
are similar while subunit 5-HT3D lacks an amino terminal CYS loop.[10] The subunits in the 
functioning unit are either arranged homo or heteromerically around a cation-specific, water filled 
central pore. Only the A subunit has been shown to form functional homomeric receptors and, 
importantly, the presence of the A subunit was required in all receptors. Adding to the functional 
complexity, heteromeric receptors contain more possible sites for allosteric modulation than 
Figure 1. Pentameric subunit arrangement of the 5-HT3 
receptor extract from PDB entry 4pir. (A): Top view (B): 
side view ECD containing (top), alpha helical TM domain 
and intracellular domain.  
A B 
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homomeric receptors.[11] Davies et al.[11] described a kinetic model of the 5-HT3 receptor 
function delineating between open, closed and desensitized states. 
A number of agonists and antagonists have been identified which are able to displace 
serotonin.[12] Among those that have significantly improved control of CINV are the “setron” 
class of antiemetics. Ondansetron and granisetron as well as the more recently introduced 
palonosetron, for example, are important tools not only for CINV but also emesis related to 
anaesthesia, surgery and radiotherapy.[13-16] Recently observations of multiple modes of 
inhibition by palonosetron, for example, exhibiting pseudo irreversible inhibition at the serotonin 
site but also acting at a distinct allosteric site, exemplifies the complexity of modulation and 
challenges to medicinal chemists.[17-21] This phenomenon has also been established for other 
CYS loop receptors. 
Empirical evidence from in vitro and clinical data suggests ginger (Zingiber officinale) may be 
an effective treatment against several types of nausea including morning sickness, motion sickness 
and chemotherapy-induced nausea and vomiting.[22, 23] Gingerols (for example 6G-10G) 
constitute the principle, non-volatile, pungent components of ginger and have been associated with 
pharmacological effects including anti-inflammatory, anti-pyretic, angiogenesis, chemopreventive 
and antioxidant activity.[24, 25]  
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These phenols contain an unbranched alkyl chain differing in length. Minor components include 
the more oxidized shogaols (for example, 6S-10S) or dehydroshogaols (for example, 6DHSG-
10DHSG). In contrast to the gingerols, both shogaols and dehydroshogaols contain an α,β-
unsaturated carbonyl group (Michael acceptor moiety) known to possess antioxidative activity and 
chemoprotective effects.[26] The principle compounds in ginger, gingerols and shogaols, have 
been demonstrated to inhibit serotonin-mediated signaling and that this interaction could be 
mediated through a currently unidentified binding site.[27],[28, 29]  In vitro studies by Abdel Aziz 
found that 6S, 6G, 8G and 10G inhibited 5-HT3-induced contractions of the isolated guinea-pig 
ileum. Since these same compounds were unable to displace the competitive antagonist, 
[3H]GR65630, from the serotonin binding site, a non-competitive mechanism was proposed. These 
results were corroborated by an in vitro study by Walstab et al.[10] which indicated that ginger 
was able to inhibit the activation of human 5-HT3 receptors and that this was likely via non-
competitive mechanisms. Additionally, since pre-incubation with 6G produced increased 
inhibition it was proposed that its binding site may be relatively inaccessible such as that of the 
transmembrane channel. As Walstab et al. noted, when combined with standard 5-HT3 antagonists, 
the non-competitive binding of ginger compounds could potentially provide an additive effect to 
the control of nausea and vomiting in clinical practice. Indeed, clinical trials have reported a 
significant improvement in CINV where ginger was combined with standard treatment with a 
setron class drug.[22, 30]  
Recently, the crystal structure of the murine 5-HT3 receptor in the apo (or unbound) form 
was solved using X-ray crystallography at 3.5Å resolution (Figure 2).[5] Prior to this, structural 
studies had relied on homology models using templates from other CYS loop receptors.[31] 
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Hassaine et al.[5] found that the binding of the VHH nanobodies resulted in potent inhibition 
(sub-nanomolar), possibly stabilizing a non-conducting conformation. Despite the relatively low 
resolution, knowledge of the three-dimensional structure has facilitated these in silico 
investigations with the aim of investigating the binding characteristics of the primary compounds 
within ginger on the 5-HT3 receptor. In particular, this study compared the binding interactions 
of gingerols, shogaols and dehydroshogaols at the serotonin site with those at the proposed 
allosteric binding site. It is hoped that this will provide additional insight into the nature of the 
binding interactions of these compounds in relation to the 5-HT3 receptor which may improve 
our understanding of these complex molecular machines and assist development of novel 
antiemetic agents. 
Materials and Methods 
Molecular Modelling 
Molecular docking, energy minimizations and structure analyses were performed using SYBYL-
X version 2.1 distributed by Certara LP (USA) (SYBYL).[32] Sites of strong binding interactions 
Figure 2. VHH nanobodies (orange) bound to 5-
HT3 receptor ECD (PDB entry: 4pir) 
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were identified using Peter Goodford’s GRID software distributed by Molecular Discovery 
Ltd.[33] 
Target and ligand library preparation  
Principle and complimentary subunits, A+/A-, were extracted from the pentameric, murine 5-
HT3 receptor structure 4pir.pdb. Extraneous ligands were removed, hydrogens added and 
Gasteiger-Huckel charges were assigned to the atoms of both protein and ligands prior to energy 
minimization (Amber FF99[34]) to a convergence of 0.5 kcal per mol.  
Known competitive antagonists, structural analogs to gingerols, non-competitive antagonists 
and decoys (molecules known not to bind to the 5-HT3 receptor) were included in the analysis in 
order to compare binding characteristics with the ginger compounds. 
To assist with interpretation, a number of scatter plots were prepared using physical 
characteristics of the ligands to look for possible correlations and trends.  
Sequence Homology 
A sequence comparison between human and mouse subunits A and B was conducted using 
ClustalOmega[35] and coloured according to the FASTA[36] scheme.  
Molecular Docking 
Docking was performed using the Surflex-Dock 2.1 algorithm.[37] Protomol generation, for the 
serotonin binding site, was based on a multi-channel approach while a residue-based approach was 
used at the allosteric binding site. This difference was due to the differences in spatial location of 
the two sites and the way in which the software defines them. The protomol at each site was 
generated using a threshold value of 0.5 and 0.9 and a bloat of 10 and 10, respectively to create a 
protomol which adequately represented each site.  
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Surflex-Dock ranks ligands in order of highest binding interaction to lowest by applying scoring 
functions, taking into account non-bonded interactions between the ligand and target, including 
hydrophobic, polar, electrostatic, van der Waal and entropic considerations. Consensus scoring 
(Cscore) calculates scores across all 4 scoring functions. Cscores are between 0-5, with a Cscore of 5 
reflecting complete consensus of the pose binding score across all scoring functions while a lower 
score indicating less consensus. The total score is expressed as -logKD to represent binding affinity. 
The lower the dissociation constant, KD, the stronger the binding. When expressed as –logKD a 
higher positive value reflects stronger binding. 
Total scores comprise the sum of a positive ‘polar’ contribution and a negative ‘crash’ score. 
The ‘crash’ score denotes the degree of inappropriate penetration of ligand atoms within the 
binding site while the ‘polar’ score incorporates the hydrogen bonding and other non-bonded 
interaction terms. Those ligands that are able to interact strongly to target residue atoms are likely 
to have higher total scores unless negative steric factors predominate.  
Figure 3 depicts the size and orientation of the protomol for the serotonin and allosteric binding 
sites respectively within which the ligands were docked. Both protomols were checked prior to 
docking to ensure ligand conformational space were included therein with a reasonable margin. 
Consensus scoring (Cscore) was included to identify structures obtaining high scores across all 4 
scoring functions. Cscores are between 0-5. A Cscore of 5 reflects complete consensus of the pose 
binding score across all scoring functions. 
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GRID Analysis 
Grid was used to elucidate potential sites of strong binding interaction between a target and a 
probe.[38]  A number of single and multi-atom probes were selected which best reflected the 
functional groups of serotonin and the ginger compounds of interest. A box of dimensions 
(topx,y,z; botx,y,z) was generated around the two sites of interest on the receptor (Supplemental 
Information Table 1 and 2).  
The resolution (number of grid points at which to calculate the interaction energy between probe 
and target) was set to (0.33Å). The LEAU parameter was set to 1 where the probe contained 2 or 
more hydrogen bond donor/acceptors, otherwise it was 0. Other settings were left at default values. 
The probes used are: water (OH2), aromatic carbon (C1=), methyl carbon (C3), phenolic hydroxyl 
oxygen (O1), alkyl hydroxyl oxygen (OH), carbonyl oxygen O, hydrophilic (DRY) and 
amphipathic (BOTH). The results for GRID probe analysis is set out in Supplemental Table 1 and 
2.  
(A)  
 Figure 3. Protomols for serotonin (A) and allosteric (B) binding sites. Connolly surface showing 
lipophilic character [polar (green) brown (non-polar)]. 
(B) 
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Results & Discussion 
The binding interactions of the ginger compounds were investigated using the recently solved 
crystal structure of the murine 5-HT3 receptor (PDB entry: 4pir). Two subunits, representing the 
principle and complementary subunits (A+A-), were extracted from the homomeric 5-HT3A 
pentamer for analysis since both the serotonin and allosteric binding sites are located at or near 
this interface (Figure 4A).  
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Figure 4. (A) Principle and complementary subunits of 5HT-3A receptor, cyan and beige ribbons 
respectively. ECD containing orthosteric binding site and allosteric site at interface with TMD; 
TMD containing M1-M4 TM helices, M2 (green) containing pore-facing residues ion (magenta); 
(B) Orthosteric binding site. (C) Proposed allosteric site: Potential key residues for binding non-
competitive antagonists (blue, ball & stick). 
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The serotonin binding site is at the interface between two adjacent subunits (Figure 4B). Key 
residues within the principle subunit, A+, include N97, N101 (Loop A) in green; T52, T54, W156 
(Loop B) in greenblue; F199, Y207 (Loop C) in blue. Residues suggested to be important for 
stabilising serotonin in the complementary subunit, A- include W63, R65, Y68 (Loop D) in yellow; 
Y124 (Loop E) in orange; D177, S179, V180 (Loop F) in red-orange; D42, D44 (Loop G) in red.[5, 
39] Two allosteric binding sites have been proposed: one situated at the interface between the 
transmembrane region and the extracellular domain; the other proposed to reside within the 
membrane.[40] The location of the former site was delineated from site-directed mutagenesis 
studies by Trattnig et al.[40] and Chang.[6] Steroids and other modulators with a more non-polar 
nature would be preferred at the latter site. The former site was selected as most appropriate for 
the ginger compounds given their physical characteristics (Figure 4C). 
A total of twenty-five ligands were incorporated into the docking experiments including 
serotonin (5-HT), 6,8 and 10-gingerol ([6G], [8G], [10G]) and 6,8 and 10-shogaol ([6S], [8S], 
[10S]), 6,8 and 10-dehydrogingerol ([6DHSG], [8DHSG], [10DHSG]). In addition, a number of 
positive and negative controls at the two sites were included. Positive controls, such as the ‘setron’ 
family of competitive antagonists, were selected based on known competitive antagonism. 
VUF10166, was selected as an example of an inhibitor able to discriminate between AB subunits 
of the 5-HT3 receptor.[41] A negative allosteric modulator (NAM), PU02, was included since it 
has been demonstrated to bind to a site which maps to an allosteric site found in other CYS-loop 
receptors. PU02 also appears to exhibit a biphasic NAM/positive allosteric modulator (PAM) upon 
mutation of certain residues in the region of this binding site.[40] Trattnig et al.[40] described the 
delicate relationship between gating and residues around this region. In addition, three known non-
competitive antagonists, including picrotoxin, likely to bind at an allosteric or alternate site were 
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included. Varenicline was included as an example of a non-specific nAchR agonist with efficacy 
at the human 5-HT receptor.[42] We also incorporated structural analogs of the gingerols 
(capsaicin and curcumin) as well as decoy molecules, smaller neurotransmitters such as 
acetylcholine and GABA, known not to bind the 5-HT3 receptor. 
A GRID analysis was performed to identify sites of strong binding interaction between the 
receptor and a range of small probes simulating various functional groups of the ligands (see 
Supplemental Table 1 and 2). Ligands were subsequently docked into the two sites to compare 
binding interactions at each site. Grid contours have been superimposed over the docked poses 
where appropriate. 
Table 1: Surflex-Dock results for Serotonin and Allosteric Sites 
    Serotonin Site  Allosteric Site 
Compound IC50  
Total 
score  
(-
logKd) 
Cscore Hbondsb Interacting Residuesc 
Total 
score 
(-
logKd) 
Cscore Hbondsb Interacting Residuesc 
Ginger Compounds 
6G 30 𝑢𝑢M (rat)i 8.7 1 3 E209 R65 8.26 1 4 E219 Q56 F222 E53 
8G 𝑢𝑢M rangeii 10.25 5 4 
T154 E209  
R65 8.84 5 3 
E53 R219 
F222 
10G 𝑢𝑢M rangeii 10.81 4 5 
T154 E209  
K211 T152 8.26 1 5 
T280 I139 
E53 Q56 
6S 9,3 𝑢𝑢M (rat)i 8.31 0 2 N101 W156 6.52 0 3 E53 F222 Q56 
8S 𝑢𝑢M rangeii 9.06 5 4 
R65 S155 
T154 7.19 2 2 K54 F222 
10S 𝑢𝑢M rangeii 9.34 2 2 T152 N101 8.29 5 1 F222 
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6DHSG - 6.97 0 3 T152 N101 K211 6.28 0 3 
E53 Q56 
K54 
8DHSG - 8.56 0 3 L157 N101 Y207  6.61 0 1 E186 
10DHSG - 9.07 2 2 L157 N101 6.85 4 3 E53 Q56 K54 
Endogenous Ligand 
serotonin 7.8 uMa,i 5.63 4 5 E173 S176 D42 D177 6.02 0 4 Q184 E53 D138 L137 
Competitive Antagonists 
Ondansetron 4.9 nM (human) 5.22 5 1 T154 4.85  0 1 Q56 
Granisetron 1.4 nM (human) 5.51 5 1 E209 4.87 0 0 - 
Palonosetron 31.6 nM (rat) 5.74 0 1 R65 5.1 0 0 - 
Dolasetron 
20.03 
nM 
(NG108-
15) 
6.9 0 3 R65  T154 5.43 1 0 - 
Ramosetron 
11-12 
nM 
(human) 
6.48 4 1 T154 5.65 2 2 P274 Q56 
VUF10166[41] 
40nM 
(AB 
subunit 
only) 
5.13 5 1 R65 5.8 4 0 - 
Agonist (non-specific) 
Varenicline[43]         
5.9 
uM[42] 
(EC50) 
5.09 4 2 R65 N101 4.23 3 1 P274 
Structural Analogues of ginger actives 
Capsaicin - 8.54 0 4 R65 N101 9.23 1 3 K54 R219 F222 
Curcumin - 8.77 0 9 
R65 T154 
S155 D177 
S179 
7.02 0 3 R219 E53 E186 
Non-Competitive Ligands 
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PU02 1.3 𝑢𝑢M (human) 5.8 5 3 D177 S179 4.33 2 1 D138 
Bicuculline 191 
𝑢𝑢M[44] 7.09 5 1 R65 6.01 1 3 - 
Picrotoxin 440 
𝑢𝑢M[44] 4.77 5 4 
E102  S150 
S136 N148 4.96 0 4 
Y46 N183 
S136 
Ginkgolide 727 
𝑢𝑢M[44] 4.25 2 7 
K211 S150 
E102 T152 
N101 
3.94 3 3 T280 D138 I139 
Decoys  
Acetylcholine - 4.9 0 0   4.95 3 1 - 
GABA - 4.9 4 3 W156 R65 4.76 1 3 - 
 
 
 
 
The docking results are presented in Table 1. Experimental inhibition assay data is included 
where available as well as the key residues with which hydrogen bonds were observed to contribute 
to the binding affinity for each ligand. For the serotonin site, total scores ranged from 4.25 to 10.81 
kcal/mol, with the ginger compounds’ scores ranging from 6.97 and 10.81 kcal/mol. The setron 
family of compounds clustered around midfield while the structural analogs scored similarly to 
the ginger compounds. Serotonin itself scored in the range of the setron compounds. The decoys 
bound with the lowest affinities (less than 5.00 kcal/mol) along with picrotoxin and gingkolide 
although bicurculline scored 7.09 kcal/mol. At the allosteric site, the total scores ranged from 3.94 
to 9.23 kcal/mol with capsaicin scoring highest. The ginger compounds also scored among the 
highest at this site ranging from 6.28 to 8.84 kcal/mol (8G). The remainder of the compounds 
followed a similar total score trend as for the serotonin site. 
IC50 data from BindingDB (http://www.bindingdb.org/bind/) unless otherwise referenced; iJin et al 2014;ii 
Wolstab et al 2010; iii Sunovak 2008; a EC50; b Hbonds = number of hydrogen bonds between key residues and 
ligand; c target residues hydrogen bonding to ligand. Residues previously identified as important for binding 
serotonin (blue). Highest scoring ligand in each site (red). 
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Comparison of the cscores for the ginger compounds at both sites reveals a relatively high degree 
of similarity. The only cases where there was significant difference was for 10G at the serotonin 
site scoring 4 compared to a 1 at the allosteric site. A cluster analysis of the 20 highest scoring 
poses for each ligand at each site was performed. The results for 10G showed much less variation 
in occupied 3D space for the 20 docked poses at the serotonin site which appears to correlate with 
the higher cscore value. This is more likely to be due to a preference for a particular conformation 
than steric constraints given the conformation space available to them. 
This trend was repeated with the structural analogs inferring that this structural family of 
compounds binds more favorably at the allosteric site. In contrast, there was a higher consensus 
for serotonin and the setron antagonists at the serotonin binding site. Consensus was high at both 
sites for the decoys, consistently performing poorly in their total scores.  
Serotonin Binding Site Results 
Of the ginger compounds, gingerols had the highest total score. A contributing factor towards 
the high score is likely to be the advantage taken of hydrogen bonding opportunities within the 
site. Both the shogaols and dehydroshogaols lack an alkyl hydroxyl group and have less flexibility 
due to the double bond. Due to their flexibility the length of their carbon chains did not negatively 
impact on their total scores. Non-competitive ligands and decoys, acetylcholine and GABA had 
the lowest score measured.  
The serotonin site has a high degree of hydrophobic character and our results are in agreement 
with this description. Figure 6 shows the predicted sites of strong interaction with a hydrophobic 
probe. A contour level of -1.5kcal/mol is indicative of a lipophilic region. Serotonin is observed 
to dock into a more polar region than the setron compounds which is as expected given their greater 
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degree of lipophilicity. A strong site of interaction correlates well with the position of the aromatic 
ring and alkyl chain of docked [6]-gingerol).  
  
The majority of ligands, including the ginger compounds, occupied a site more interior and 
hydrophobic than that bound by serotonin (Figure -B and C). Despite the 3 apparent hydrogen 
bonds with D177 and one each between S179 and W165, the total score for serotonin was lower 
than all ginger compounds, structural analogs, granisetron, dolasetron and romasetron. 
The serotonin site is lined with a number of aromatic residues, termed the ‘aromatic box’ and 
provides stability to the site.  
Figure 8A shows the three particularly strong sites of interaction with a hydrophobic probe. and 
correlate well with the docked positions of hydrophobic moieties of the ligands such as the alkyl 
tails of the ginger compounds and the aromatic ring systems of other compounds. Contours for a 
Figure 6. 5-HT and 10G docked into serotonin site. Hydrophobic probe 
(orange contours). Note the site where 5HT3 is bound is more polar than 
the site occupied by 10G. 
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cationic amine probe showed excellent correlation to the site of the docked ammonium group of 
serotonin (Figure 8B).  
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The gingerols compounds are distinguished from the other more oxidized ginger compounds by 
Figure 8. Serotonin binding site (A) Docked ginger compounds (atom types) and I (magenta). 
Hydrophobic probe contoured at -1.5kcal/mol. (B) I with contours for hydrophobic probe (yellow, 
-1 kcal/mol) and amine probe (blue, -15kcal.mol) (C) Docked poses of 6,8 and 10G with alkyl 
hydroxyl probe contours (green-blue, 10.5kcal/mol) (D) Docked poses of 6,8 and 10S with phenyl 
hydroxyl probe contours (-10.5 kcal/mol, yellow) (E) Docked poses of 10G with carbonyl oxygen  
probe contours (-7 kcal/mol, red-orange) (F) Docked 6G with contours for aromatic probe (red, -
3.5 kcal/mol) 
(A) (B) 
(C) (D) 
(E) 
Grid prediction for cationic amine 
(F) 
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the presence of an alkyl hydroxyl group. Sites of polar interactions with an alkyl hydroxyl group 
correlates well with the position of alkyl hydroxyl probe of 6G (Figure 8C). Similarly, the docked 
positions of a carbonyl oxygen and aromatic rings correlated well with the sites predicted by GRID 
(Figure 8E and 8F). Sites of binding interactions predicted by GRID between a phenyl hydroxyl 
probe was less well correlated with the docked position of the same group in 6G (Figure 8D). 
There are a number of valid reasons why the results from GRID would not always be expected to 
overlap with similar moiety positions in docked poses. Apart from different algorithms for 
determining interactions, docking algorithms deal with entire molecules rather than simply small 
moieties and thus are more spatially restricted. Nevertheless, it is of interest to view the site in pure 
terms of particular functional group interactions.  
 
 
 
 
 
 
 
 
 
 
 
A 
(B) 
Figure 9. (A) Ligand rotatable bonds compared to total score and polar surface 
area. (B)  Ligand clogP values versus total score and coloured by volume. 
5-HT3 
[8]-gingerol (A) 
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Unexpectedly, the ginger compounds scored highest in the serotonin binding site. In terms of 
drug-like characteristics, the ginger compounds have a high non-covalent interaction potential 
meaning that they possess a range of structural moieties required for maximizing binding affinity. 
These include an aromatic ring (pi stacking), alkyl tail (hydrophobic and Van der Waal 
interactions), hydrogen bond donors (phenol and hydroxyl) and acceptors (carbonyl and hydroxyl 
oxygens) for maximizing hydrogen bonding interactions. The ginger compounds have a high 
degree of flexibility as illustrated by the observed correlation between rotatable bonds and total 
score (Figure 9). The same features are similarly found in the structural analogs, capsaicin and 
curcumin which also scored highly in the serotonin binding site. In addition to flexibility, there is 
a clear correlation between hydrophobic character and total score with all the top scoring ginger 
compounds and structural analogs having high, positive clogP values. Volume is similarly 
positively correlated with total scores. 
Current molecular docking algorithms are limited in their capacity to accurately model all factors 
present in vivo. Target flexibility, explicit solvent and some types of non-covalent interactions, for 
example, are often not considered or dealt with poorly. As a result, caution in the interpretation of 
these results is required. Interactions between both competitive and non-competitive antagonists 
with the receptor have been described by Thompson et al.[39] to undergo a pathway as they 
progress from bound to unbound which may involve several transient sites. Furthermore, the 
nicotinic receptor, AChBP, also of the CYS loop receptor is known to undergo substantial 
quaternary twisting of the subunit interface upon activation of the ion channel and bending of the 
extracellular domain.[45] It is feasible then to consider similar conformational movements of the 
5-HT3 receptor and concomitant changes to binding sites. In this light, it is not surprising that we 
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see the ginger compounds binding well to this site. The crystal structure was assumed to have 
adopted a closed conformation upon binding of the inhibitory VHH nanobody. It is possible that 
serotonin may have scored higher had the receptor been in a more open channel conformation and 
ligand ranking likely to be quite different. 
Binding studies reveal a complexity in mechanisms of action with respect to how particular 
ligands may interact with different subunit stoichiometry. The potent inhibitor, VUF10166 for 
example, was found to displace granisetron at the orthosteric binding site in an A+A- binding site 
but acted at an alternate site at an A+B- binding.[46] The 5-HT3A crystal structure used in this 
study was homomeric (A+A-).  
Prior to the determination of the mouse crystal structure, site directed mutagenesis studies 
revealed a number of residues important for activation of the 5-HT3 receptor or binding of 
serotonin.[47] These included Y46, F103, S136 and D138 (mouse numbering). These dues are 
more posterior to the serotonin site shown in the mouse structure and were not seen to interact with 
any of the ligands. In the crystal structure, however, Hassaine et al.[5] further identified several 
key residues in the crystal structure as important for serotonin binding. For example, we found that 
R65 played a key role in binding ligands at the serotonin site and supports experimental 
observations. Several ginger compounds, structural analogs and competitive antagonists interacted 
with this residue through hydrogen bonding. In addition, N101 and T154 were also important for 
stabilizing ligands via hydrogen bonding. Serotonin was found to interact with D42 and D177 as 
well as S179. These residues were implicated by Hassaine et al.[5] as forming the serotonin binding 
site. The residues forming the most hydrogen bond interactions with the ligand database were R65, 
N101 and T154. Ginger ligands formed hydrogen bonds with several residues, predominantly R65, 
T154 and N101. We found previously unidentified residue, E102, contributed to stabilization of 
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[10]-dehydroshogaol. The setron group of ligands docked into two main regions within the site. 
Ondasetron and dolasetron bound closer to the complementary site where 5-HT3 was found to 
interact while granisetron and romasetron bound closer to the primary subunit face. Palonasetron 
was docked in between these regions (Figure 10A).  
Possible pi stacking interactions between Y207 were identified which may confer stability to the 
docked ligands with 10G and other ligands such as curcumin (Figure 10B). Other competitive 
Figure 10. (A) Granisetron (atom colours) ondasetron (orange) dolasetron (green) romasetron 
(yellow) palonosetron (red). (B) Curcumin (atom colours) docked into serotonin site. Additional 
stability by possible pi stacking interaction with Y207. (C) Capsaicin docked into serotonin site 
depicting the aromatic box created by Y207, W156 (primary subunit, blue) and Y126 & W63 
(complementary subunit, beige). (D) Serotonin (atom colours) and 10G (magenta). Hydrophobic 
probe contoured at -1.5 kcal/mol for C and D. 
(A) (B) 
Y207 
Y207 
W156 
Y126 
W63 
R65 
R169 
R65 
(C) (D) 
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antagonists interacted predominantly with R65 and T154; both of which also interacted with 
gingerols.  
Our docking results are in agreement with these residues as important for hydrogen bonding 
with the site. Figure 10-C clearly depicts the aromatic box of the serotonin site created by the 
residues Y126, and W63 of the complementary subunit and Y207 and W156 of the primary 
subunit. The high scoring ginger compounds and their structural analogs were observed to dock in 
a similar orientation with their aromatic ring embedded in this box permitting hydrogen bonding 
with the side chain cationic amine of R65. In contrast, serotonin’s aromatic ring appears to take 
advantage of a cation-pi interaction with R65 (Figure-10D). This interaction was proposed by 
Hassaine et al[5] with granisetron. We further suggest that a second cation-pi interaction on the 
opposite face of serotonin’s aromatic ring is possible with R169.  
Allosteric Binding Site Analysis  
Allosteric modulation facilitates fine tuning of ion permeation through the channel by signal 
dampening, for example, depending on the stoichiometry of the subunits and the number of 
serotonin ligands able to bind one receptor. Multiple modes of regulation have been noted in other 
CYS-loop receptors and are similarly likely in the serotonin receptor and involve a number of 
allosteric binding sites. Endogenous membrane lipids have been suggested to modulate ion 
permeation by binding to specific regions of the transmembrane channel. Exactly where non-
competitive antagonists of the 5-HT3 receptor may bind is yet to be fully elucidated.   
The transmembrane domain of the CYS-loop receptors are functionally similar with key regions 
along the length of the ion permeation pathway being designated with a prime notation such that 
the pre-M2 region, identified as -20’ contains a ring of cationic residues.[46] Certain residues of 
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the M2 helix face in toward the channel (Figure 11) and site-directed mutagenesis studies have 
identified a number to important for channel function. 
Furthermore, non-competitive antagonists (NCAs) such as picrotoxin can differentiate different 
subunit compositions in the receptor.[48] The most likely position for many of the exogenous 
NCAs is the intersubunit interface at the top of the transmembrane domain. Another allosteric site 
is proposed in the pre-M2, ECM intersubunit interface. Anesthetics and small alcohols have been 
shown to interact at a similar site in GABA and glycine receptors.[49, 50] These compounds illicit 
similar effects on the 5-HT3 receptor.[11] Since the structure of one such anesthetic, lidocaine, had 
a degree of structural similarity to serotonin and the ginger compounds, our study focused on the 
latter allosteric site.  
 
Figure 11. (A) Docked ligands within the allosteric binding site at the ECM/TM interface between 
primary and complementary subunits. Side view with M2 TM helix (green) (B) Superimposition of 
docked ligands at the allosteric site. 8G (magenta). Docked picrotoxin indicated position closer 
towards serotonin binding site.  Alkyl tails of 8,10S and 6,10DHSG.  
M2 helix 
Ion 
permation 
pathway 
Outer ECM region 
TM domain 
picrotoxin 
Alkyl tail of 
[8],[10]-S and 
[6],[10]DHSG 
serotonin 
binding site 
(A) (B) 
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The orientation of the docked ligands within the allosteric binding site is depicted in Figure 10A 
with contoured surface coloured according to lipophilic character (Figure 11B). Note that 
picrotoxin is bound to a unique site midway between the serotonin and allosteric sites. This ligand 
may bind to a different allosteric site with the A+B- subunit interface. The allosteric binding site 
depicted occupies a greater volume than that of the serotonin binding site, enabling some ginger 
compounds to adopt a more extended conformation. This appears to facilitate a favourable 
hydrophobic interaction between the alkyl moiety of these ligands with the hydrophobic region 
found closer to the transmembrane domain.  
 
 
 
 
 
 
 
 
The ginger compounds and structural analogs also scored highest in this binding site with 
capsaicin attaining the highest total score. As demonstrated by the lower level of contouring for 
the hydrophobic probe, the allosteric site is more polar than the serotonin cavity although there are 
particular regions with hydrophobic character which correlate well with hydrophobic moieties of 
the ligands (Figure 12A). Figure 12B shows sites of strong interaction with a water probe which 
correlate well with the docked positions of polar groups on the ligands. 
Figure 11. Top scoring ligand, capsaicin at allosteric site. (A): GRID contours for a 
hydrophobic probe (-0.5kcal/mol). (B): GRID contours for a water probe (-11kcal/mol). 
Connolly surface coloured by lipophilic character. 
(A) (B) 
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Comparison between the different ginger compounds showed that the gingerols generally 
scoring higher as a group (Figure 13) with all three adopting a similar orientation within the site. 
This trend is continued with the shogaols scoring generally higher than the dehydroshogaols. This 
trend correlates with the higher polarity of the gingerols compared to the other ginger compounds 
and, in this context, would therefore bind with higher affinity in a more polar site. 
Serotonin and the competitive antagonists ranked moderately at this site with all setron ligands 
binding in a similar location to the gingerols (Figure 14A and B). PU02 occupied a unique site 
lower down toward the transmembrane region forming a pi stacking interaction with Y140. (Figure 
14-C) 
R219 
N56 
I139 
N184 
D138 
K54 
Y140 
Figure 12. Superimposition of 6G (atom colours), 8G (yellow), 10G (violet) in allosteric site.  
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Our analysis identified R219, Q56, F222, E53, K54 and T280 as the key binding residues for 
this site with minor contributions from I139, P279 and E186. The key residues important for 
forming hydrogen bonds with the ginger compounds were I139, R219, Q56, F222, and Q53. F222, 
in particular, was involved with hydrogen bonding with all shogaols and most gingerols.  
Compared to serotonin and the ginger compounds, other competitive antagonists exhibited 
relatively low levels of hydrogen bonding interactions within the allosteric site suggesting less 
available hydrogen bond donors/acceptors at this site compared to the serotonin site. Flexibility 
Figure 13. Allosteric site: (A) Serotonin docked into allosteric site with amine cation probe 
contoured at -15kcal/mol (B) Setrons (granisetron (atom colours), ondansetron (orange), 
dolasetron (green), romasetron (yellow) palonosetron (red ) (C) Potential pi stacking interaction 
between PU02 and Y56. 
(A) (B) (C) 
Figure 15. (A) Scatter plots of rotatble bonds Vs Total score with colour axis, clogP (B) Scatter plots of 
Volume Vs Total score with colour axis, clogP. 
(A) (B) 
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played a positive role in how well the ligands scored at this site as it did within the serotonin site 
(Figure 15-A). Volume and increasing hydrophobicity were observed to play a similar role in 
contributing to a higher total score. (Figure 15-B). 
A sequence alignment (Figure 16) was performed of the mouse and human 5-HT3A and B 
receptors to map the key residues identified in the mouse structure with those in the human receptor 
subunits and determine if the newly identified residues were conserved. Human and mouse A 
subunits share 84.7% sequence identity. Human and mouse B subunits share 73.2% sequence 
identity. Human A and B subunits share 44.75% identity whereas mouse A and B share 42.4% 
identity. It was found that all key residues important for binding the ginger compounds (as well as 
serotonin) in the serotonin site were conserved between human and mouse A subunits. For clarity, 
mouse numbering is noted in red while human sequence numbering was in black. Hassaine et al.[5] 
noted the importance of R218 at the TM interface and we show here this residue to be conserved 
in both the human A and B subunits. Note that E102 identified in this analysis was found to be 
similarly conserved. For the allosteric site, all residues noted as important for binding the ginger 
compounds were conserved between mouse and human sequences. Given the high degree of 
sequence similarity between the mouse and human subunits and the conservation of those 
important receptors, it is unlikely that the species difference would account for the finding that the 
ginger compounds bound well in both sites. 
A comparison of the present docking results to available biological IC50 data is presented in 
Table 2. Compounds were listed in order of potency at the human 5-HT3 receptor (where data was 
available).   
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Figure 16. Sequence alignment for human and murine 5-HT3 receptor 
subunits A and B. FASTA colouring scheme (red lipophilic; blue acidic, 
magenta basic, green polar). Key residues for principle subunit (blue shaded 
box), complementary subunit (grey shaded box); pore-facing residues of 
TM2 (red star), TM regions M1-M4 (underlined). 
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In a saturation study performed by Walstab et al.[10], a competitive antagonist was present and 
likely bound at the orthosteric site. Under these conditions, due to their flexibility and relative non-
specificity for a particular binding site, the ginger compounds may bind at the allosteric site to 
illicit their effect since they were unable to displace GR10655. It remains to be confirmed under 
similar experimental conditions, whether the ginger ligands would bind in the absence of any 
competitive antagonist and thus allow classification as either an uncompetitive inhibitor or mixed 
inhibitor. A similar dual role has been observed for amide-type local anaesthetics, lidocaine and 
bupivacaine.[49] Structural characteristics of the ginger compounds which could contribute to 
their capacity to bind well in different environments are their flexibility and combination of both 
a degree of polarity and hydrophobic character. These structural features could enable the ginger 
compounds to exploit the specific complementarity at each site. 
Our results could reflect the structural changes that occur in the transition from open to closed 
channel conformations. Serotonin binds with high affinity to the open conformation. Hassaine et 
al.[5], speculated that the crystal structure they produced is in the closed conformation. Thus it is 
possible that the overall score of serotonin was lower than what may have been observed for the 
open conformation. Additionally, the crystal structure depicts an A+A- subunit homomeric 
structure. Given the five currently identified subunits, varying degrees of binding affinity would 
be expected by all ligands with the concomitant changes to the binding site. Allosteric modulators 
are more potent in the heteromeric receptors. To test this idea in the absence of another crystal 
structure, work is in progress to prepare a homology model of an A+B- and a B-A+ receptor using 
a three dimensional template from the current 5-HT3 receptor.  
To date no 5-HT3 crystal structures exists with a ligand bound to either the serotonin binding or 
the allosteric site 5-HT3 receptor. High resolution, three dimensional structures of other cation 
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selective CYS loop receptors, such as the nicotinic acetylcholine receptor (nAChR-α1) have been 
published which share a high degree of structural and functional similarity to the 5-HT3 receptor. 
While we investigated the two key sites identified to date in this study, it is also possible that 
additional binding sites for allosteric regulation exist. Future studies could explore other areas of 
the receptor such as the transmembrane region.  
We also acknowledge the following limitations. Only one crystal structure of the 5-HT3 receptor 
is currently available and while this allows for in silico investigation of this receptor, the crystal 
structure was from mouse rather than human origin and not highly resolved leading to likely 
discrepancies in the positioning of target atoms. Attempts to address the sequence differences 
between species were carried out using sequence homology and it was noted that most of the key 
residues are well conserved. Rigid docking approaches of this kind rely on the position of the 
sidechain atoms. Errors of this nature impact heavily on the ability to accurately test 
conformational space sufficiently well to find the most realistic binding poses. The effects of the 
low resolution X-ray imaging has been somewhat reduced by conducting energy minimization on 
the target prior to docking to relieve any initial strain in the conformation of the protein although 
gross misplacement of atoms/residues side-chains will not be compensated for by this measure. 
Since some of the key binding residues have long, flexible side chains (R219, K54, R65) and thus 
have a high degree of mobility, docking algorithms incorporating more flexible approached would 
be preferable. Molecular dynamics (MD) simulations incorporating explicit solvent would also 
alleviate some of the limitations mentioned above.  
Conclusion 
In this study, we investigated the binding interactions of ginger 6G, 8G and 10G, 6S, 8S and 
10S and 6DHSG, 8DHSG and 10DHSG, as well as several known competitive and non-
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competitive antagonists at the orthosteric and allosteric binding sites on the 5-HT3 receptor. 
Notably, the ginger compounds scored highly at both sites along with the structural analogs, 
capsaicin and curcumin. It has been proposed that the ginger compounds elicit their effect through 
an allosteric modulation of the 5-HT3 receptor. Our results support this hypothesis. Within the 
serotonin site, a high degree of hydrogen bonding and flexibility was proposed to contribute to 
their high score. Additionally, they also scored higher than other non-competitive antagonists at 
the allosteric site. Likewise, at the allosteric site, a high degree of hydrogen bonding and flexibility 
likely contributed to their overall high total. The finding that the ginger compounds outscored 
serotonin and other competitive antagonists at the serotonin site may have a number of possible 
explanations. It is hoped that this work will lead to a deeper understanding of the interactions 
between these ginger compounds and the 5-HT3 receptor and ultimately aid in the design of more 
potent and specific antagonists to alleviate those who suffer CINV. Until the crystal structures of 
either a ligand-bound murine or, the more relevant human 5HT3 receptor we continue our work to 
gain further insight into the nature of these interactions. 
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